Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy - Nishimoto, N; Miyasaka, N; Yamamoto, K (Mod Rheumatol, 2009)
et al.